Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 0 | 0 | 34 | 17 | 8 |
| Cost of Goods | N/A | N/A | 61 | 4 | 8 |
| Gross Profit | N/A | N/A | -27 | 13 | 0 |
| Operating Expenses | 373 | 251 | 81 | 29 | 26 |
| Operating Income | -373 | -251 | -47 | -13 | -18 |
| Other Income | -30 | -20 | 0 | 0 | 0 |
| Pre-tax Income | -403 | -272 | -47 | -13 | -18 |
| Income Tax | N/A | N/A | N/A | N/A | -2 |
| Net Income Continuous | -403 | -272 | -46 | -13 | -16 |
| Net Income | $-403 | $-272 | $-46 | $-13 | $-16 |
| EPS Basic Total Ops | -0.05 | -0.03 | 0.00 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.05 | -0.03 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.05 | -0.03 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.05 | -0.03 | 0.00 | -0.01 | -0.01 |
| EBITDA(a) | $-355 | $-234 | $-47 | $-13 | $-18 |